Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psychiatry Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psychiatry Other
    Vaccine Inoculations Show No Link to Autism, Other Health Problems: Presented at IDSA - (DGDispatch)
    Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents - (JAMA)
    Use of Antipsychotic Medications by Children and Adolescents Associated With Significant Weight Gain - (DGNews)
    The Clinical Course of Advanced Dementia - (N Engl J Med)
    Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study - (BMJ)

    News archive

     Recent webcasts/CME - Psychiatry Other

    Webcasts/CME archive

     Recent cases - Psychiatry Other
      Female Sexual Dysfunction as a Comorbid Illness
      11p Microdeletion Including WT1 but not PAX6, Presenting with Cataract, Mental Retardation, Genital Abnormalities and Seizures: Case Report
      Comorbidity of Asperger's Syndrome and Bipolar Disorder
      Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
      Treating Bipolar Disorder in Patients with Renal Failure Having Haemodialysis: Two Case Reports

      Cases archive
        




      my personal edition > psychiatry other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Mirtazapine-Amitriptyline Combination Warrants Caution

      A DGReview of :"Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects"
      Human Psychopharmacology: Clinical and Experimental

      03/12/2003
      By David Loshak


      Combined daily administration of the noradrenergic/serotonergic enhancer mirtazapine and the tricyclic anti-depressant amitriptyline alters their pharmacokinetics only slightly but, the combination should be used with caution, say researchers in Oss, the Netherlands.

      Adding one drug to the other or substituting one for the other had no major effects on tolerability, they added.

      The researchers assessed both the steady-state pharmacokinetics of the two agents together compared with each alone, and their tolerability and effects on psychometric tests of acute and sub-chronic administration, also together or alone. Twelve healthy men and women were assigned to six different sequences of three 9-day treatments. A placebo group of four men and four women were studied as well, during the first treatment period to control for acute pharmacodynamic assessments.

      Serial blood samples were drawn for plasma level measurements and pharmacokinetic analysis. Psychometric tests assessed performance. Computer-assisted telephone questionnaires assessed self-ratings of drowsiness, alertness and sleep quality.

      Amitriptyline increased the Cmax of mirtazapine by a significant 36% in men but not women. Mirtazapine significantly altered the Cmax of amitriptyline in both sexes, increasing it by 23% in men and lowering it by 23% in women. There were no other changes in pharmacokinetic parameters. Metabolite parameters were not affected either.

      Changes in parent compound levels resulted mainly from effects on absorption. Psychometric test results did not disclose any significant differences between combined and single drug treatments.

      The questionnaires did not disclose any clinically relevant differences between the active treatments.
      Human Psychopharmacology: Clinical and Experimental 2003;18:2:91-101. "Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send